Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a culturally adapted workshop break the cycle of HIV stigma?

NCT ID NCT07786441

Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study tests Kabawil, a workshop-based program adapted from an existing HIV stigma reduction intervention, to see if it can reduce HIV-related and intersectional stigmas among Indigenous men who have sex with men and traditional healers in Guatemala. Participants will either attend the workshop or join a wait-list control group, and researchers will measure changes in stigma and HIV care engagement. The goal is to determine if the intervention is feasible, acceptable, and effective in improving HIV outcomes in these communities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A culturally adapted workshop-based stigma reduction intervention called Kabawil
What this could lead to
If successful, this could provide a proven, culturally tailored approach to reduce HIV stigma in Indigenous communities, potentially improving HIV prevention and care engagement.
What could go wrong
This is an early-phase study with a small number of participants, so results may not generalize. The intervention's effectiveness depends on community acceptance and long-term sustainability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 year of age and older * Self identifies as a man who has had sex with other men * Self identifies as traditional healer Exclusion Criteria: * Requires working knowledge of Spanish * Minor (under age 18)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stigma, social are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stigma, social

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Washington

    RECRUITING

    Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.